GlassScriptPhysician profile
Jeri L Spurlock
NPI 1336420298
$2,848.04
in general payments reported to CMS, 2019-2025
14 companies · $1,852 in 2025
The $1,852 reported for 2025 was more than what 91% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $107 · 2023: $379 · 2024: $354 · 2025: $1,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285 · Travel and Lodging: $1,218 · Education: $81.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.41 |
| Travel and Lodging | $1,218.03 |
| Education | $81.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,613.14 | 2021-2025 | Spravato, Invega Sustenna |
| Abbvie INC. | $231.25 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $217.29 | 2021-2024 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $199.74 | 2024-2025 | Cobenfy |
| Lundbeck LLC | $185.61 | 2022-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $130.14 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Axsome Therapeutics, INC. | $107.13 | 2022-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $53.14 | 2025 | |
| Alkermes, INC. | $42.20 | 2022-2025 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $17.58 | 2023 | Austedo Xr |
| Idorsia Pharmaceuticals US INC | $15.31 | 2022 | |
| Merck Sharp & Dohme LLC | $12.91 | 2023 | Belsomra |
| Corium, LLC | $12.76 | 2022 | |
| Sunovion Pharmaceuticals INC. | $9.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeri Spurlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.